Investor Stock List
Ranked #1,779 of 8,699 institutional investors

Kynam Capital Management, LP

Princeton, NJ

$1.57B
US stock portfolio at live prices · today +$11.2M (+0.72%)
Market closed. Prices as of Nov 20, 8:11 AM ET
Value at quarter end (Q3 2026)
$1.81B
Change from Q2 2026
−$3.3M (−0.18%)
Positions
31 · 4 new, 2 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$128M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
VRDN 12.3%PCVX 9.70%LEGN 9.39%CLDX 9.02%COGT 6.70%
StockSharesValue, live% of portfoliovs Q2 2026
VRDN Viridian Therapeutics, Inc.6,148,000$193M12.3%Reduced −5%
PCVX Vaxcyte, Inc.2,607,964$152M9.70%Reduced −11%
LEGN Legend Biotech Corporation9,154,389$147M9.39%Added +205%
CLDX Celldex Therapeutics, Inc.5,066,051$142M9.02%Reduced −5%
COGT Cogent Biosciences, Inc.3,792,289$105M6.70%Added +3%
TVTX Travere Therapeutics, Inc.2,000,000$96.6M6.15%Unchanged
BEAM Beam Therapeutics Inc.3,933,894$82.4M5.25%Added +38%
VERA Vera Therapeutics, Inc.3,000,000$80.3M5.11%Added +4%
SNDX Syndax Pharmaceuticals, Inc.8,150,959$74.4M4.74%Added +1%
MBX MBX Biosciences, Inc.934,799$49.9M3.18%Unchanged
RLAY Relay Therapeutics, Inc.2,751,500$43.8M2.79%Reduced −17%
CTMX CytomX Therapeutics, Inc.21,140,726$43.3M2.76%Reduced −3%
IMCR Immunocore Holdings plc1,375,000$36.6M2.33%Unchanged
SMMT Summit Therapeutics Inc.3,000,000$31.7M2.02%Added +150%
CGEM Cullinan Therapeutics, Inc.3,114,132$28.2M1.80%Unchanged
BCRX BioCryst Pharmaceuticals, Inc.2,522,660$18.5M1.18%Unchanged
BNR Burning Rock Biotech Limited1,238,563$16.5M1.05%Unchanged
NRIX Nurix Therapeutics, Inc.1,194,757$16.2M1.04%Unchanged
SRZN Surrozen, Inc.486,252$14.9M0.95%New
XENE Xenon Pharmaceuticals Inc.280,000$10.5M0.67%New
ALEC Alector, Inc.4,308,494$9.9M0.63%Added +13%
EVMN Evommune Inc1,200,000$8.7M0.55%New
STRO Sutro Biopharma, Inc.872,558$7.6M0.48%Unchanged
PRLD Prelude Therapeutics Incorporated2,311,955$7.5M0.48%Reduced −4%
PBLS Parabilis Medicines, Inc.250,000$6.9M0.44%Unchanged
GERN Geron Corporation6,836,318$6.2M0.40%Unchanged
AMRN Amarin Corporation plc532,982$6.0M0.38%Unchanged
HROW Harrow, Inc.124,655$4.0M0.26%New
ENGN enGene Therapeutics Inc.457,855$806K<0.1%Unchanged
CRBU Caribou Biosciences, Inc.2,503,302$777K<0.1%Unchanged
TRAW Traws Pharma, Inc.84,400$19K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
INSM Insmed Incorporated100,000$14.4M
CADL Candel Therapeutics, Inc.96,741$496K